Education: Opioid Use Disorder (OUD)
OPIOID USE DISORDER: SCREENING, ASSESSMENT, AND REASSESSMENT; MEDICATION MANAGEMENT AND INTEGRATION INTO PRACTICE; AND SPECIAL POPULATIONS (On-Demand Webinar)
This webinar is made available with support from the American Psychiatric Association Innovative Grant program.
Michelle O’Brien, MD, Psychiatrist, Specialty Behavioral Health Services, El Rio Health, 2020-2021 Addiction Medicine Fellow, University of Arizona College of Medicine, Tucson
Jamie Weinand, MD, Associate Medical Director - Grant Health Center, El Rio Health, 2020-2021 Addiction Medicine Fellow, University of Arizona College of Medicine, Tucson
Elisa Gumm, DO, Medical Director of Addiction Services, Southern Arizona Veteran Affairs Health Care System, and Clinical Assistant Professor, Program Director, Addiction Medicine Fellowship, University of Arizona College of Medicine, Tucson
Edwin Kim, MD, Addiction Psychiatrist, Medical Director, Charles O'Brien Center for Addiction Treatment at the University of Pennsylvania, Medical Director, Pennsylvania Physician Health Program, and Consultant, Arizona Physician Health Program
Accreditation StatementIn support of improving patient care, this activity has been planned and implemented by American Psychiatric Association (APA) and the Arizona Psychiatric Society. The American Psychiatric Association (APA) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Designation StatementThe American Psychiatric Association (APA) designates this enduring material activity for a maximum of 3.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Planning CommitteeThank you to the Planning Committee members for their contributions to this educational outreach.
Christina Arredondo, MD; Jasleen Chhatwal, MBBS, MD, FAPA; Monica Faria, MD; Don J. Fowls, MD ; Elisa Gumm, DO; Edwin Kim, MD; Gurjot Marwah, MD; Ole J. Thienhaus, MD; Jamie Weinand, DO; Staff, Teri Harnisch; and Staff, Ashley Schnock
Faculty and Planner DisclosuresThe American Psychiatric Association adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Medical Education. Any individuals in a position to control the content of a CME activity — including faculty, planners, reviewers or others — are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.
The faculty and planners for this activity have no relevant financial interests to disclose. How to Earn CreditParticipants who wish to earn AMA PRA Category 1 Credit™ or a certificate of participation may do so by completing all sections of the course including the evaluation. Upon registration, participants will be provided with instructions on how to access and complete the course and the steps required to complete the evaluation and claim their CME Certificate or a certificate of participation.
Target AudiencePsychiatric physicians and physicians of other specialties providing screening, assessment, and treatment for opiate use disorder, and other health care providers authorized to oversee medications for opiate use disorder or who are part of the health care team treating OUD.